The Power of Personalized Care in Cancer Treatment

Genomics testing provide precision personalized care in cancer prevention, diagnosis, and treatment. By pinpointing distinct genetic variations in cancer cells, it directs tailored treatment plans that ensure effectiveness, minimize side effects, and can potentially reduce costs. This personalized strategy transforms patient care, focusing on the unique genetic makeup of each cancer for optimized treatment outcomes.
About the speaker:
Professor Leong has extensive experience in the field of genomics, having received several prestigious awards, including the FMD Fellowship (USA), the Institute of Biomedical Science President's Award (UK), and the Top Research Scientist Malaysia (TRSM). He was previously a Senior Research Fellow at Harvard Medical School and Massachusetts General Hospital in Boston, USA. Dr. Leong is currently a Fellow of the Institute of Biomedical Science (FIBMS, UK), Fellow of the Royal Society of Biology (FRSB, UK), and Fellow of the Royal Society of Chemistry (FRSC, UK). He served as a professor of genomics and Deputy Director of Research at the International Medical University, Malaysia. He is the founder and CEO of AGTC Genomics, a technology company that specializes in advanced genomics technology and also holds the position of adjunct professor and visiting fellow at the Broad Institute of Harvard and MIT.